1-20 of 68
Xin Li
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

BCMA CAR-T-Cell Therapy in Combination with Long-Term Pomalidomide Is a Safe and Effective Treatment for Relapsed/Refractory Multiple Myeloma

Yuhan Yan, Yixuan Tu, De-Pei Wu, Xin Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 2116.
https://doi.org/10.1182/blood-2023-181573
Published: 2023
Journal Articles

Circulating Exosomal miRNA Signature As a Potential Risk Factor for DNA Virus Infection in Patients with Multiple Myeloma

Xin Chen, Liwen Wang, Zuqun Deng, Yishu Tang, Qian Cheng, Depei Wu, Xin Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 1926.
https://doi.org/10.1182/blood-2023-185287
Published: 2023
Journal Articles

Efficacy and Safety of Chemotherapy (DDGP vs VIPD) Followed Radiotherapy Vs Radiotherapy Followed Chemotherapy (DDGP vs VIPD) Vs Radiotherapy Alone for Newly Diagnosed Early Stage Extranodal Natural Killer/T Cell Lymphoma: Final Results of a Prospective, Multicenter, Randomized, Controlled Clinical Trial

Mingzhi Zhang, Lei Zhang, Xin Li, Ling Li, Xinhua Wang, Xiaorui Fu, Zhenchang Sun, Yu Chang, Xudong Zhang, Hui Yu, Feifei Nan, Zhiyuan Zhou, Xiyang Liu, Xiaolong Wu, Liqun Zou, Hui Zhou, Hongwei Xue
Journal: Blood
Blood (2023) 142 (Supplement 1): 1690.
https://doi.org/10.1182/blood-2023-188245
Published: 2023
Journal Articles

A Prediction Model for Early Recurrence after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with CMML: A Nationwide Representative Multicenter Study

Jianying Zhou, Song Wang, Ting Niu, Ming Jiang, Shunqing Wang, Wen Wang, Xi Zhang, Yujun Dong, Dingming Wan, Xin Du, Xudong Wei, Han Zhu, Yuhua Li, Kehong Bi, Xianmin Song, Yi Chen, Li Liu, Yi Luo, Yuhong Zhou, Xin Li, Yajing Xu, Yicheng Zhang, Xiaoliang Liu, Hai Yi, Xiaobing Huang, Zunmin Zhu, Jianmin Yang, Fang Zhou, Xiaohui Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 4951.
https://doi.org/10.1182/blood-2023-184407
Published: 2023
Journal Articles

Efficacy and Safety of Ino Combined with Reduce Dose R-GDP Regimen in Patients with Relapsed/Refractory B-Cell NHL in China

Xin Li, Rui Cui, Jia Wang, Juan Mu, Yili Jiang, Jingyi Li, Lugui Qiu, QI Deng
Journal: Blood
Blood (2023) 142 (Supplement 1): 6880.
https://doi.org/10.1182/blood-2023-182822
Published: 2023
Journal Articles

A Phase 1 First-in-Human Monotherapy Study of F182112, a B-Cell Maturation Antigen (BCMA)-CD3 Bispecific Antibody, in Patients with Relapsed or Refractory Multiple Myeloma

Mingyuan Sun, Junyuan Qi, Lugui Qiu, Jie Jin, Xin Li, Yongqiang Wei, Guimin Zhang, Xue Liu, Shaohong Yin
Journal: Blood
Blood (2023) 142 (Supplement 1): 1978.
https://doi.org/10.1182/blood-2023-178948
Published: 2023
Journal Articles

Comparison of Efficacy and Side Effects of BTK Inhibitors for Different Duration As a Bridging Therapy before Anti-CD19-CAR T-Cell Therapy in Patients with R/R DLBCL

QI Deng, Jia Wang, Rui Cui, Juan Mu, Xin Li, Qing Li, Lugui Qiu
Journal: Blood
Blood (2023) 142 (Supplement 1): 3482.
https://doi.org/10.1182/blood-2023-182855
Published: 2023
Journal Articles

A Phase I/II Study of Orelabrutinib Combined with Anti-Programmed Cell Death Protein-1 Antibody and Fotemustine for Patients with Newly Diagnosed Primary Central Nervous System Lymphoma (PCNSL)

Xudong Zhang, Wenhua Wang, Shanshan Ma, Mengke Fan, Linan Zhu, Lei Zhang, Xin Li, Ling Li, Zhenchang Sun, Xinhua Wang, Xiaorui Fu, Zhaoming Li, Jiaqin Yan, Mingzhi Zhang
Journal: Blood
Blood (2022) 140 (Supplement 1): 12075–12076.
https://doi.org/10.1182/blood-2022-159383
Published: 2022
Journal Articles

Phase I Study of a Novel Oral Proteasome Inhibitor TQB3602 in Relapsed/Refractory Multiple Myeloma

Wenjiao Tang, Yan Li, Qiushi Liang, Ying Qu, Li Zhang, Yuzhang Liu, Baijun Fang, Zeng Yun, Xiaobo Du, Yaming Xi, Ting Wang, Xin Li, Jie Huang, Wenbin Qian, Zhen Cai, Qingwei Zhao, Yue Lv, Ting Niu
Journal: Blood
Blood (2022) 140 (Supplement 1): 4396–4397.
https://doi.org/10.1182/blood-2022-168091
Published: 2022
Journal Articles

The Impact of the Immunophenotyping Characteristics of Patients' Peripheral Blood on the Manufacturing and Clinical Outcome of CD7-Targeted Chimeric Antigen Receptor T Cells

Mingzhi Zhang, Xiaorui Fu, Huimin Meng, Min Wang, Yu Wang, Guifang Pan, Lei Zhang, Ling Li, Xin Li, Xinhua Wang, Zhenchang Sun, Hui Yu, Zhaoming Li, Feifei Nan, Yu Chang, Zhiyuan Zhou, Jiaqin Yan, Jiwei Li, Xiaolong Wu, Yanmei Zhao, Yu-Sheng Chen, Fengtao You, Dan Chen, Tingting Zhang, Bozhen Zhang, Lin Yang
Journal: Blood
Blood (2021) 138 (Supplement 1): 3830.
https://doi.org/10.1182/blood-2021-147632
Published: 2021
Journal Articles

A Single-Arm, Open-Label, Pilot Trial of Autologous CD7-CAR-T Cells for CD7 Positive Relapsed and Refractory T-Lymphoblastic Leukemia/Lymphoma

Mingzhi Zhang, Xiaorui Fu, Huimin Meng, Min Wang, Yu Wang, Lei Zhang, Ling Li, Xin Li, Xinhua Wang, Zhenchang Sun, Hui Yu, Zhaoming Li, Feifei Nan, Yu Chang, Zhiyuan Zhou, Jiaqin Yan, Jiwei Li, Xiaolong Wu, Guifang Pan, Yanmei Zhao, Yu-Sheng Chen, Fengtao You, Lin Yang
Journal: Blood
Blood (2021) 138 (Supplement 1): 3829.
https://doi.org/10.1182/blood-2021-149999
Published: 2021
Journal Articles

CD20-Specific Chimeric Antigen Receptor-Expressing T Cells As Salvage Therapy in Rituximab-Refractory CD20(+) B-Cell Non-Hodgkin Lymphoma

Xin Li, Qian Cheng, Rui Liu, Liqing Kang, Nan Xu, Minghao Li, Lei Yu
Journal: Blood
Blood (2021) 138 (Supplement 1): 2845.
https://doi.org/10.1182/blood-2021-150477
Published: 2021
Journal Articles

Ixazomib Based Maintenance Therapy for the Patients with Newly Diagnosed Multiple Myeloma in Real-World Practice

Liye Zhong, Yongqiang Wei, Baohong Ping, Xin Li, Hongling Peng, Yongqain Li, Yuyang Tian, Zelin Liu, Jun Luo, Yongzhong Su, Haifei Chen, Yanjuan He, Hongliang Li, Congming Wu, Zhiqiang Sun, Keqian Shi, Xiaoliang Li, Qing Zhang, Guoyu Hu, Gang Huang, Zhenqian Huang, Weida Wang, Zhongjun Xia
Journal: Blood
Blood (2021) 138 (Supplement 1): 2718.
https://doi.org/10.1182/blood-2021-149058
Published: 2021
Journal Articles

Anti-PD-1-Antibody (Tislelizumab) Combined with Deacetylase Inhibitor (Chidamide), Lenalidomide and Etoposide for the Treatment of Refractory/Relapsed Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (r/r-ENKTL): Preliminary Results from a Prospective, Multicenter, Single -Arm, Phase II Trial

Lei Zhang, Xiyang Liu, Xinhua Wang, Yu Chang, Xiaorui Fu, Xin Li, Ling Li, Jiaqin Yan, Feifei Nan, Xiaolong Wu, Linan Zhu, Zhenchang Sun, Hui Yu, Mingzhi Zhang
Journal: Blood
Blood (2021) 138 (Supplement 1): 1368.
https://doi.org/10.1182/blood-2021-152020
Published: 2021
Journal Articles

Fotemustine-Based in Combination with Rituximab As First-Line Induction Chemotherapy for Newly Diagnosed Primary Central Nervous System Lymphoma:a Prospective Phaseii Trial

Jingjing Wu, Fenghua Gao, Lei Zhang, Xin Li, Ling Li, Xinhua Wang, Linan Zhu, Xudong Zhang, Xiaorui Fu, Zhenchang Sun, MD, PhD, Meng Dong, Mengjie Ding, Hui Yu, Feifei Nan, Jiaqin Yan, Yu Chang, Xiaolong Wu, Zhiyuan Zhou, Mingzhi Zhang, MD, Ken H. Young
Journal: Blood
Blood (2020) 136 (Supplement 1): 5.
https://doi.org/10.1182/blood-2020-137449
Published: 2020
Journal Articles

Low-Dose Decitabine Plus Venetoclax Maintenance Therapy Can Decrease the Relapse after Allogeneic Stem Cell Transplantation for MRD Positive High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

Yunxiong Wei, Yaqing Cao, Xin Jin, Xiaoyuan He, Rui Sun, Xia Xiong, Wenyi Lu, MD, Xin Li, Xia Xiao, MD, Hairong Lyu, Mingfeng Zhao, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 33.
https://doi.org/10.1182/blood-2020-140359
Published: 2020
Journal Articles

CD19 CAR-T Cells Treatment Conferred a Sustained Remission in Patients with Chemotherapy-Refractory MRD in B-ALL

Wenyi Lu, MD, Yunxiong Wei, Yaqing Cao, Xia Xiao, MD, Qing Li, Hairong Lyu, Yili Jiang, Huan Zhang, Jia Wang, Xin Li, Yanyu Jiang, Meng Juanxia, Yuan Ting, Haibo Zhu, Xiaoyuan He, Xin Jin, Rui Sun, Tao Sui, Kaiqi Liu, Mingfeng Zhao, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 48.
https://doi.org/10.1182/blood-2020-140431
Published: 2020
Journal Articles

Single-Cell Transcriptome of Early Hematopoiesis Guides Arterial Endothelium-Promoted Functional T Cell Generation from Human Pluripotent Stem Cells

Jun Shen, Yingxi Xu, Shuo Zhang, Shuzhen Lyu, Zack Wang, PhD, Min Wang, MD, Xin Li, Tao Cheng
Journal: Blood
Blood (2020) 136 (Supplement 1): 38.
https://doi.org/10.1182/blood-2020-140609
Published: 2020
Journal Articles

Efficacy and Survival in Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma: A Randomized, Controlled, Multicenter and Open-Labled Study with Ddgp Regimen Versus SMILE Regimen

Xinhua Wang, MD PhD, Lei Zhang, Xiangli Liu, Xin Li, Ling Li, Xiaorui Fu, Zhenchang Sun, Jingjing Wu, Xudong Zhang, Jiaqin Yan, Yu Chang, Feifei Nan, Zhiyuan Zhou, Xiaolong Wu, Li Tian, Wencai Li, Hongwei Xue, Jinghua Wang, Liqun Zou, Liping Su, Yi Lu, Yanzhen Guo, Ken H. Young, Mingzhi Zhang
Journal: Blood
Blood (2019) 134 (Supplement_1): 463.
https://doi.org/10.1182/blood-2019-127811
Published: 2019
Journal Articles

Efficacy and Safety of Apatinib in Relapsed or Refractory Diffuse Large B Cell Lymphoma: An Open-Label, Single-Arm, Prospective Study

Xinran Ma, MSc, Ling Li, Lei Zhang, Xin Li, Xiaorui Fu, Xinhua Wang, PhD, Jingjing Wu, Xudong Zhang, Xiaoyan Feng, Zhiyuan Zhou, Yu Chang, Zhaoming Li, MD PhD, Ken H. Young, Mingzhi Zhang
Journal: Blood
Blood (2019) 134 (Supplement_1): 2873.
https://doi.org/10.1182/blood-2019-127912
Published: 2019